Transdermal Drug Delivery Systems Powered by Artificial Intelligence
Advanced Healthcare Materials · 2025-12 · 14 (32)
DOI: 10.1002/adhm.202503030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 16.10.2025. Verfasst von Farzaneh Sabbagh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosystems and Soft Matter, Institute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, 02-106, Poland. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Delivery Systems. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 148 Literaturangaben. Gefördert von: BioRender.com under the academic license, Narodowe Centrum Nauki.
Abstract (Originalsprache)
Transdermal drug delivery systems (TDDSs) offer non‐invasive therapy but face persistent challenges. Artificial intelligence (AI) transforms TDDSs by leveraging machine learning (ML) and predictive analytics to address these barriers. ML models predict drug entrapment with 93.0% accuracy, streamlining development. AI enhances transdermal patch formulations by forecasting drug release kinetics, skin penetration, and stability, minimizing reliance on costly clinical trials. Through virtual screening, AI identifies novel drug candidates and permeation enhancers, accelerating innovation. In microneedle systems, AI optimizes geometries, materials, and drug loading, improving precision and personalization. AI‐integrated biosensors enable real‐time monitoring, supporting adaptive dosing tailored to individual physiological profiles. Compared to traditional modeling, AI provides superior accuracy and scalability, handling complex datasets to reveal non‐linear relationships. Despite challenges like data quality and privacy concerns, AI's integration with 3‐dimensional printing and stimuli‐responsive materials drives the development of personalized, efficient transdermal therapies. This perspective highlights AI's critical role in advancing therapeutic efficacy and patient‐centric care in TDDSs, uniquely combining predictive modeling with real‐time monitoring to envision next‐generation personalized transdermal delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biosystems and Soft Matter, Institute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, 02-106, Poland.
- Data Science Research Centre, School of Computing, University of Derby, Derby, DE22 1GB, UK.
ORCID-Profile: Filippo Pierini
Förderung
- BioRender.com under the academic license
- Narodowe Centrum Nauki
Zitieren
APA
Sabbagh, F., Zakrzewska, A., Rybak, D., Król, J., Abdi, A., Nakielski, P., & Pierini, F. (2025). Transdermal Drug Delivery Systems Powered by Artificial Intelligence. Advanced Healthcare Materials, 14(32). https://doi.org/10.1002/adhm.202503030
Vancouver
Sabbagh F, Zakrzewska A, Rybak D, Król J, Abdi A, Nakielski P, et al. Transdermal Drug Delivery Systems Powered by Artificial Intelligence. Advanced Healthcare Materials. 2025;14(32). doi:10.1002/adhm.202503030
BibTeX
@article{Sabbagh2025,
author = {Sabbagh, Farzaneh and Zakrzewska, Anna and Rybak, Daniel and Król, Julia and Abdi, Asad and Nakielski, Paweł and Pierini, Filippo},
title = {Transdermal Drug Delivery Systems Powered by Artificial Intelligence},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {32},
doi = {10.1002/adhm.202503030}
}
EUVIMED